ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 188 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $303,000 | -56.5% | 12,500 | -58.1% | 0.01% | -56.2% |
Q4 2021 | $696,000 | -38.6% | 29,839 | -56.2% | 0.02% | -33.3% |
Q3 2021 | $1,133,000 | -31.1% | 68,203 | +1.2% | 0.02% | -33.3% |
Q2 2021 | $1,644,000 | -56.8% | 67,410 | -54.3% | 0.04% | -57.1% |
Q1 2021 | $3,806,000 | -46.0% | 147,500 | +12.0% | 0.08% | -38.2% |
Q4 2020 | $7,042,000 | +30.0% | 131,734 | +0.3% | 0.14% | -5.6% |
Q3 2020 | $5,416,000 | +15.2% | 131,299 | +35.4% | 0.14% | +6.7% |
Q2 2020 | $4,702,000 | +16.7% | 97,000 | +1.7% | 0.14% | -14.0% |
Q1 2020 | $4,030,000 | -0.8% | 95,386 | +0.4% | 0.16% | +137.9% |
Q4 2019 | $4,064,000 | +29.8% | 95,000 | +9.2% | 0.07% | +4.8% |
Q3 2019 | $3,131,000 | +4.6% | 87,000 | -22.3% | 0.06% | -20.3% |
Q2 2019 | $2,994,000 | -0.4% | 112,000 | 0.0% | 0.08% | +5.3% |
Q1 2019 | $3,007,000 | +69.0% | 112,000 | +1.8% | 0.08% | +1.4% |
Q4 2018 | $1,779,000 | -38.8% | 110,000 | -21.4% | 0.07% | -3.9% |
Q3 2018 | $2,906,000 | +46.4% | 140,000 | +7.7% | 0.08% | +63.8% |
Q2 2018 | $1,985,000 | +10.4% | 130,000 | +62.5% | 0.05% | -17.5% |
Q1 2018 | $1,798,000 | +59.3% | 80,000 | +113.3% | 0.06% | +96.6% |
Q4 2017 | $1,129,000 | +19.9% | 37,500 | +50.0% | 0.03% | -17.1% |
Q3 2017 | $942,000 | +35.2% | 25,000 | 0.0% | 0.04% | +20.7% |
Q2 2017 | $697,000 | -19.0% | 25,000 | 0.0% | 0.03% | -14.7% |
Q1 2017 | $860,000 | +54.4% | 25,000 | +42.9% | 0.03% | 0.0% |
Q3 2016 | $557,000 | -5.9% | 17,500 | -4.0% | 0.03% | -26.1% |
Q2 2016 | $592,000 | -39.5% | 18,225 | -47.9% | 0.05% | +9.5% |
Q1 2016 | $979,000 | -32.2% | 35,000 | -13.6% | 0.04% | -57.6% |
Q4 2015 | $1,444,000 | +7.8% | 40,500 | 0.0% | 0.10% | +67.8% |
Q3 2015 | $1,339,000 | -64.5% | 40,500 | -55.0% | 0.06% | -60.4% |
Q2 2015 | $3,769,000 | +20.5% | 90,000 | -6.2% | 0.15% | +7.2% |
Q1 2015 | $3,129,000 | -10.4% | 96,000 | -12.7% | 0.14% | +15.8% |
Q4 2014 | $3,493,000 | +28.2% | 110,000 | 0.0% | 0.12% | +79.1% |
Q3 2014 | $2,724,000 | +4.8% | 110,000 | -4.3% | 0.07% | +17.5% |
Q2 2014 | $2,598,000 | +1.7% | 115,000 | +9.5% | 0.06% | +9.6% |
Q1 2014 | $2,555,000 | +5.0% | 105,000 | +7.8% | 0.05% | 0.0% |
Q4 2013 | $2,434,000 | -31.8% | 97,410 | -25.1% | 0.05% | +36.8% |
Q3 2013 | $3,570,000 | +107.0% | 129,996 | +36.8% | 0.04% | -24.0% |
Q2 2013 | $1,725,000 | – | 95,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |